ASTELL SCIENTIFIC LIMITED

1. Financial Health Score: A (Excellent)

Astell Scientific Limited presents the financial equivalent of a remarkably fit and resilient constitution. With a robust balance sheet, strong liquidity, and consistent profitability, the company exhibits no critical signs of financial distress. The only minor symptoms to monitor are a slight shift in fluid dynamics—specifically, cash converting into inventory—which warrants a routine check-up rather than emergency intervention.

2. Key Vital Signs

• Pulse (Liquidity & Working Capital): The company’s current ratio sits at a highly healthy 2.47 (Current Assets of £2.76M / Current Liabilities of £1.12M). This means the business has nearly £2.50 in liquid assets for every £1 of short-term debt. Its financial "blood flow" is excellent, ensuring operational expenses and suppliers can be paid with ease.
• Blood Pressure (Solvency & Leverage): Net assets have grown to £2.24 million, up from £1.98 million in the prior year, with no signs of long-term debt strain. Total liabilities (£1.16M) are comfortably covered by total assets (£3.4M). The business is not over-leveraged, maintaining a very healthy "blood pressure."
• Muscle Growth (Profitability): The Profit and Loss reserve grew from £1,355,176 to £1,611,944—an organic increase of £256,768. This retained profit acts as a strong layer of muscle, demonstrating that the core business (manufacturing autoclaves and precision equipment) is generating healthy returns and reinvesting them into the company's reserves.
• Immune Reserves (Cash Position): Cash at bank stands at £992,036. While slightly down from the prior year's £1.13M, this remains a formidable cash pile, acting as an excellent immune system against unexpected market shocks or supply chain disruptions.

3. Diagnosis

Overall Condition: Excellent. Astell Scientific is a long-standing business (incorporated in 1950) that demonstrates the financial stability of a mature, well-managed enterprise.

Symptoms Analysis: While the overall diagnosis is exceptionally positive, a diagnostic comparison of the balance sheets reveals a slight shift in the company's financial fluid dynamics: * Cash Conversion Cycle: Cash dropped by roughly £144k, while Stocks (inventory) increased by roughly £119k (from £659k to £778k). This suggests the business is carrying more inventory than the previous year. For a manufacturing firm, this could simply be strategic purchasing or building stock for future orders, but it does tie up capital. * Reduced Short-Term Liabilities: Trade creditors fell from £1.3M to £1.1M. The company is paying off its short-term obligations faster, which is great for credit health but naturally depletes cash reserves. * Provisions: Provisions for liabilities increased from £24k to £41k. This is a minor symptom—akin to a mild inflammation—that suggests the company is anticipating future costs (perhaps related to warranties on their machinery or deferred consideration), but it is easily covered by their robust reserves.

4. Recommendations

To maintain peak financial wellness and optimize the company's operational efficiency, the following preventative measures and lifestyle adjustments are recommended:

1. Inventory Circulation Check: With a notable increase in stock levels, management should ensure inventory turnover remains brisk. Stagnant stock can act like fluid retention, tying up vital cash. Review aged inventory to identify slow-moving lines and consider liquidating them to restore cash to its prior peak.
2. Strategic Cash Deployment: With nearly £1 million in cash and retained earnings steadily building, the business has more financial nutrients than it currently needs for day-to-day survival. Consider whether this cash could be better deployed—whether through higher-yield deposit accounts, strategic capital expenditure (upgrading machinery to boost productivity), or returning value to shareholders via dividends.
3. Monitor the Provisions: Keep an eye on the growing provision for liabilities. Ensure the underlying causes are well-documented and that these potential future outflows do not become chronic.